Date: October 26, 2022 By: Emily Makowski
Congratulations to Dr. Brandon DeKosky, the 2022 James S. Huston Antibody Science Talent Award recipient!
This award is given annually by The Antibody Society to an early career researcher who has made important contributions to antibody science. DeKosky and his lab have developed a suite of high-throughput single-cell platforms for large-scale analyses of adaptive immunity. Key application areas include infectious disease interventions, especially malaria and HIV-1 prevention, and the development of personalized cancer therapeutics.
The award is named for Dr. James Huston, who developed single-chain variable fragment proteins and co-founded The Antibody Society. It includes international recognition of scientific accomplishments, a $1500 prize, and opportunities to present work at the Antibody Engineering & Therapeutics conference in December and in a recorded session that will be made available for future viewing on the Antibody Society’s website.
For more information about the award, visit the Antibody Society website.
A collaborative effort between researchers from Uganda, Tanzania, the US, Spain, and Denmark has resolved a longstanding question in malaria research: Do individuals living in regions with continuous malaria transmission develop broadly neutralizing antibodies (BnAbs) against the malaria parasite? The answer is yes.
Researchers at the Ragon Institute of Mass General Brigham, MIT, and Harvard have uncovered critical insights into how aging impairs the immune system’s ability to fight cancer.